20 / 22
Median OS in
BRAF
Mutant 2nd-Line mCRC
1. De Roock W et al.
Lancet Oncol
. 2010;11:753-62; 2. Ulivi P et al.
J Transl Med
. 2012;10:87; 3. Peeters M et al.
J Clin Oncol
. 2014;32:5s (suppl; abstr 3557); 4. Saridaki Z et al.
PLoS One
.
2011;6:e15980; 5. Loupakis F et al.
BJC
. 2009;101:715-21
Retrospective evaluation of a limited dataset can only be hypothesis generating
Regimen
Number of Patients
Median OS, mo
Cetux-CT
1
24
6
Cetux-CT
2
12
5.8
FOLFIRI
3
23
5.7
FOLFIRI-Pani
3
22
4.7
Cetux-CT
4
8
4.3
Cetux-Iri
5
13
4.1
FOLFIRI
20
5.5
FOLFIRI-Aflib
16
10.3
VELOUR
Presented by Tejpar S at ESMO WGIC 2017